Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

Cell Source, Inc

+1 (646) 416-7896
Website

Advertisement

Advertisement

57 W 57th St Ste 400
New York, NY 10019
+1 (646) 416-7896
https://cell-source.com

Cell Source, Inc is a biotechnology company based in New York, NY that specializes in cellular therapy research and development.

With a focus on innovative solutions for regenerative medicine, Cell Source, Inc is dedicated to advancing the field of cell-based therapies through cutting-edge technology and scientific expertise.

Generated from their business information

Also at this address

Elite Real Estate Group LLC

Mitzu Hair

yelp logo
5 reviews
Manicure

Lash Moment Studio

yelp logo
10 reviews

Yanker, Drew

Own this business?
Claim it
See a problem?

You might also like

Xalud Therapeutics

Xalud Therapeutics is a clinical-stage biotechnology company based in New York, NY, that is dedicated to developing a non-viral plasmid DNA-delivered gene therapy platform to treat chronic inflammatory diseases by restoring balance in the immune system. Their lead candidate, XT-150, is a locally injectable gene therapy that expresses a modified version of interleukin-10 (IL-10v), a potent cytokine that regulates multiple inflammatory pathways. Xalud aims to transform the treatment of chronic inflammatory diseases by addressing the underlying cause of the disease and improving the lives of patients burdened by these conditions.Generated from the website

Absci Ai Research Lab

Absci Ai Research Lab is a generative AI drug creation company based in New York, NY. They are dedicated to creating better biologics for patients at a faster pace by designing antibodies from scratch using their zero-shot AI approach. Their breakthrough technology combines AI with synthetic biology to overcome the limitations of traditional drug discovery, enabling them to build and test millions of AI designs every week and validate new biologic-based therapeutics in as little as six weeks. Absci's innovative platform has the potential to disrupt the biopharmaceutical industry, with collaborations and partnerships with leading companies such as Merck, AstraZeneca, EQRx, and Almirall. Their powerful data generation and AI protein engineering platform, coupled with their unique disease biology insights, is revolutionizing drug discovery and production, offering innovative and cost-effective treatment options for patients.Generated from the website
Surgical instruments and apparatus

Dominari Holdings Inc

Spherix Incorporated was launched in 1967 as a scientific research company, under the name Biospherics Research. Through the years the company has maintained a strong focus on innovation. Its BioSpherix division is currently running a Phase 3 clinical trial to study the use of the company's Naturlose product as a treatment for Type 2 diabetes. Spherix Health Sciences Consulting division provides scientific and strategic support for suppliers, manufacturers, distributors and retailers of: conventional foods, biotechnology-derived foods, medical foods, infant formulas, food ingredients, dietary supplements, food contact substances, pharmaceuticals, medical devices, consumer products and industrial chemicals and pesticides. It has corporate headquarters in Beltsville, Md., and additional offices in Maryland, Tennessee and South Dakota.
United States›New York›New York›Cell Source, Inc

Partial Data by Infogroup (c) 2024. All rights reserved.

Partial Data by Foursquare.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell